Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1AN | Q9NWT6 | 15/20 | 0.65 |
| ▸ | ODC1 | P11926 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.61 |
| ▸ | RELA | Q04206 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31376188 | 0.93 | HIF1AN (0.75) | HIF1ANODC1NFKB1NFKB2RELA | |
| SCHEMBL31376261 | 0.93 | ODC1 (0.75) | HIF1ANODC1NFKB1NFKB2RELA | |
| SCHEMBL31376262 | 0.93 | HIF1AN (0.75) | HIF1ANODC1NFKB1NFKB2RELA | |
| SCHEMBL16245064 | 0.91 | HIF1AN (0.67) | HIF1ANODC1NFKB1NFKB2RELA | |
| SCHEMBL14315437 | 0.91 | HIF1AN (0.67) | HIF1ANODC1NFKB1NFKB2RELA | |
| Xanthohumol C SCHEMBL12961704 | 0.91 | NFKB1 (0.65) | HIF1ANODC1NFKB1NFKB2RELA | |
| Xanthohumol C SCHEMBL14249680 | 0.91 | NFKB1 (0.65) | HIF1ANODC1NFKB1NFKB2RELA | |
| Xanthohumol C SCHEMBL30066955 | 0.91 | NFKB1 (0.65) | HIF1ANODC1NFKB1NFKB2RELA | |
| SCHEMBL31376226 | 0.91 | ODC1 (0.60) | HIF1ANODC1NFKB1NFKB2RELA | |
| SCHEMBL31376266 | 0.90 | ACHE (0.70) | HIF1ANODC1NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504685-A | Benzopyran flavonoid compound, preparation method and application thereof, and pharmaceutical preparation | 南开大学 | 2025-02-25 | — | — | CN | disclosed |